In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides

被引:16
作者
Bacchi, CJ
Sanabria, K
Spiess, AJ
Vargas, M
Marasco, CJ
Jimenez, LM
Goldberg, B
Sufrin, JR
机构
[1] PACE UNIV,DEPT BIOL,NEW YORK,NY 10038
[2] ROSWELL PK CANC INST,GRACE CANC DRUG CTR,BUFFALO,NY 14263
[3] ROSWELL PK CANC INST,DEPT EXPT THERAPEUT,BUFFALO,NY 14263
关键词
D O I
10.1128/AAC.41.10.2108
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
5'-Deoxy-5'-(methylthio)adenosine (MTA), a key by-product of polyamine biosynthesis, is cleaved by MTA phosphorylase and is salvaged as adenine and, through conversion of the ribose moiety, methionine. An analog of MTA, 5'-deoxy-5'-(hydroxyethylthio)adenosine (HETA), is a substrate for trypanosome MTA phosphorylase and is active in vitro and in vivo against Trypanosoma brucei brucei, an agent of bovine trypanosomiasis. In this study, BETA and three O-acylated BETA derivatives were examined for their activities against model infections of T. b. brucei and Trypanosoma brucei rhodesiense, the agent of East African sleeping sickness, BETA was curative (> 60%) for infections caused by 5 of 11 clinical isolates of T. b. rhodesiense when it was given to mice at 200 mg/kg of body weight for 7 days as a continuous infusion in osmotic pumps, BETA at 150 to 200 mg/kg also extended the life spans of the mice infected with four additional isolates two- to fivefold, Di-and tri-O-acetylated derivatives of BETA also proved curative for the infections, while a tri-O-propionyl derivative, although also curative, was not as effective, This study indicates that substrate analogs of MTA should be given important consideration for development as novel chemotherapies against African trypanosomiasis.
引用
收藏
页码:2108 / 2112
页数:5
相关论文
共 25 条
  • [1] ABELES RH, 1992, ALDRICHIM ACTA, V25, P3
  • [2] RESISTANCE TO DL-ALPHA-DIFLUOROMETHYLORNITHINE BY CLINICAL ISOLATES OF TRYPANOSOMA-BRUCEI-RHODESIENSE - ROLE OF S-ADENOSYLMETHIONINE
    BACCHI, CJ
    GAROFALO, J
    CIMINELLI, M
    RATTENDI, D
    GOLDBERG, B
    MCCANN, PP
    YARLETT, N
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 46 (03) : 471 - 481
  • [3] DIFFERENTIAL SUSCEPTIBILITY TO DL-ALPHA-DIFLUOROMETHYLORNITHINE IN CLINICAL ISOLATES OF TRYPANOSOMA-BRUCEI-RHODESIENSE
    BACCHI, CJ
    NATHAN, HC
    LIVINGSTON, T
    VALLADARES, G
    SARIC, M
    SAYER, PD
    NJOGU, AR
    CLARKSON, AB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1183 - 1188
  • [4] 5'-ALKYL-SUBSTITUTED ANALOGS OF 5'-METHYLTHIOADENOSINE AS TRYPANOCIDES
    BACCHI, CJ
    SUFRIN, JR
    NATHAN, HC
    SPIESS, AJ
    HANNAN, T
    GAROFALO, J
    ALECIA, K
    KATZ, L
    YARLETT, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1315 - 1320
  • [5] BACCHI CJ, UNPUB
  • [6] Bacchi Cyrus J., 1995, P119, DOI 10.1016/B978-012473345-9/50008-8
  • [7] BACKLUND PS, 1981, J BIOL CHEM, V256, P1533
  • [8] Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6
  • [9] CHARACTERIZATION OF PENTAMIDINE-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI
    BERGER, BJ
    CARTER, NS
    FAIRLAMB, AH
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 69 (02) : 289 - 298
  • [10] ANTITRYPANOSOMAL EFFECTS OF POLYAMINE BIOSYNTHESIS INHIBITORS CORRELATE WITH INCREASES IN TRYPANOSOMA-BRUCEI-BRUCEI S-ADENOSYL-L-METHIONINE
    BYERS, TL
    BUSH, TL
    MCCANN, PP
    BITONTI, AJ
    [J]. BIOCHEMICAL JOURNAL, 1991, 274 : 527 - 533